Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Picropodophyllin-d6

Picropodophyllin-d6 (AXL1717-d6) is deuterium labeled Picropodophyllin. Picropodophyllin (AXL1717) is a selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 of 1 nM.

Product Specifications

Product Name Alternative

AXL1717-d6; Picropodophyllotoxin-d6; PPP-d6

UNSPSC

12352005

Target

Apoptosis; IGF-1R; Isotope-Labeled Compounds

Type

Isotope-Labeled Compounds

Related Pathways

Apoptosis; Others; Protein Tyrosine Kinase/RTK

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Cancer; Endocrinology

Solubility

10 mM in DMSO

Smiles

O=C1OC[C@]2([H])[C@@H](O)C3=C(C=C4OCOC4=C3)[C@@H](C5=CC(OC([2H])([2H])[2H])=C(OC([2H])([2H])[2H])C(OC)=C5)[C@@]21[H]

Molecular Formula

C22H16D6O8

Molecular Weight

420.44

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Bieghs L, et al. The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic. Oncotarget. 2014 Nov 30;5 (22) :11193-208.|[3]Girnita A, et al. Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth. Cancer Res. 2004 Jan 1;64 (1) :236-42.|[4]Kong YL, et al. Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1/IGF-1R pathway. Acta Pharmacol Sin. 2016 Feb;37 (2) :217-27.|[5]Menu E, et al. Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model. Blood. 2006 Jan 15;107 (2) :655-60. Epub 2005 Jul 26.|[6]Stromberg T, et al. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells. Blood. 2006 Jan 15;107 (2) :669-78. Epub 2005 Sep 15.|[7]Tomizawa M, et al. Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells. Oncol Lett. 2014 Nov;8 (5) :2023-2026. Epub 2014 Aug 27.

Shipping Conditions

Room temperature

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MRGX3 Blocking Peptide
MBS8243437-01 1 mg

MRGX3 Blocking Peptide

Ask
View Details
MRGX3 Blocking Peptide
MBS8243437-02 5 mg

MRGX3 Blocking Peptide

Ask
View Details
MRGX3 Blocking Peptide
MBS8243437-03 5x 5 mg

MRGX3 Blocking Peptide

Ask
View Details
RABGGTA (Geranylgeranyl Transferase Type-2 Subunit alpha, Geranylgeranyl Transferase Type II Subunit alpha, Rab Geranyl-geranyltransferase Subunit alpha, Rab GG Transferase alpha, Rab GGTase alpha, Rab Geranylgeranyltransferase Subunit alpha)
132238 50 µg

RABGGTA (Geranylgeranyl Transferase Type-2 Subunit alpha, Geranylgeranyl Transferase Type II Subunit alpha, Rab Geranyl-geranyltransferase Subunit alpha, Rab GG Transferase alpha, Rab GGTase alpha, Rab Geranylgeranyltransferase Subunit alpha)

Ask
View Details
Osteopontin (SPP1) Antibody
abx349959-01 50 µL

Osteopontin (SPP1) Antibody

Ask
View Details
Osteopontin (SPP1) Antibody
abx349959-02 100 µL

Osteopontin (SPP1) Antibody

Ask
View Details